Tübingen, Germany-based CureVac, a biopharmaceutical company developing transformative medicines based on mRNA, announced on Tuesday, February 7, the ...
Editorial team
|
February 9, 2023
TargED Biopharmaceuticals, an Utrecht-based biotechnology company focused on developing improved treatments for thrombotic diseases, announced that it has ...
February 24, 2022
Submission based on positive data from two pivotal studies, which both met their primary endpoints U.S. clearance expected ...
Business Wire
May 14, 2025
Projected economic benefits of using AI-powered detection/diagnostic Software as a Medical Device, like eyonis® LCS, will be presented ...
May 12, 2025
In recent days, the tech industry has witnessed a wave of advancements. From groundbreaking AI developments to shifts ...
Vigneshwar Ravichandran
May 3, 2025
QIAcuity digital PCR kits, assays and protocols for lentivirus-based therapies support quality control in cell and gene therapy ...
April 29, 2025
Returns to FY revenue growth in 2024 (+3.3%), with acceleration in H2 (+10.2%) Slight decrease in operating loss, ...
With the technology developing at breakneck speed, it’s nearly impossible to keep up with every breakthrough, funding round, ...
April 26, 2025
€6.0 million in Q1 2025 revenues, up 11% over Q1 2024 €74.8 million all-time high order backlog as ...
April 24, 2025
Debiopharm announces oral and poster presentations on data from their potential first-in-class compound Debio 1562M, a CD37-targeted ADC, ...
April 22, 2025
All secondary endpoints required to support eyonis™ LCS’ intended use and desired marketing claims achieved in RELIVE eyonis™ ...
March 31, 2025
BOSTON–(BUSINESS WIRE)–OM1, a leading provider of real-world data (RWD) and AI-driven insights for life sciences, today announced its ...
March 12, 2025
01
02
03
04
05
More
[wp_dark_mode style="2"]
01
Celebrating 20 years of driving ‘High-Tech’ innovation: Berlin to host HTGF Family Day 2025; 4 reasons to join